Nuvaxovid is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
The company is bringing precision therapies for gynaecological cancers
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Subscribe To Our Newsletter & Stay Updated
